Article
STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma.
European urology - 1 Apr 2013
Eto Masatoshi, Kamba Tomomi, Miyake Hideaki, Fujisawa Masato, Kamai Takao, Uemura Hirotsugu, Tsukamoto Taiji, Azuma Haruhito, Matsubara Akio, Nishimura Kazuo, Nakamura Tsuyoshi, Ogawa Osamu, Naito Seiji
Abstract excerpt
BACKGROUND: In our 2007 retrospective study, we reported that single nucleotide polymorphisms (SNPs) in the signal transducer and activator of transcription 3 (acute-phase response factor) (STAT3) gene were significantly associated with better response to interferon (IFN)-α in patients with metastatic renal cell carcinoma (mRCC). OBJECTIVE: To prospectively confirm those results, the Japan Immunotherapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
